CLINICAL AND DOSIMETRIC PREDICTORS OF ACUTE TOXICITY AFTER A 4-WEEK...
biblio.ugent.be
Stefano Arcangeli, Lidia Strigari, Guy Soete, Gert De Meerleer (UGent) , Sara Gomellini, VALERIE FONTEYNE, Guy Storme and Giorgio ...
Radiotherapy in Prostate Cancer: Innovative Techniques and Current ...books.google.co.in › books
books.google.co.in
... Zürich, Switzerland Giorgio Arcangeli Regina Elena National Cancer Institute, Rome, Italy Stefano Arcangeli Regina Elena National Cancer Institute, ...
Modelling Radiotherapy Side Effects: Practical Applications ...books.google.com › books
books.google.de
Arcangeli, Giorgio, Biancamaria Saracino, Stefano Arcangeli, Sara Gomellini, Maria Grazia Petrongari, Giuseppe Sanguineti, and Lidia Strigari “Moderate ...
Radiotherapy in Prostate Cancer: Innovative Techniques and Current ...books.google.de › books
books.google.de
... University Hospital Zurich, Zürich, Switzerland Giorgio Arcangeli Regina Elena National Cancer Institute, Rome, Italy Stefano Arcangeli Regina Elena National ...
Optimal scheduling of hypofractionated radiotherapy for localized ...pubmed.ncbi.nlm.nih.gov › ...
pubmed.ncbi.nlm.nih.gov
Authors. Giorgio Arcangeli , Stefano Arcangeli , Valentina Pinzi , Michaela Benassi , Marcello Benassi , Lidia Strigari ...
Dose escalation using ultra-high dose IMRT in intermediate risk...
jeccr.biomedcentral.com
Maria Grazia Petrongari*, Valeria Landoni, Biancamaria Saracino, Sara Gomellini, Stefano Arcangeli, Giuseppe Iaccarino, Paola Pinnarò, Giorgio Arcangeli and ...
Radiotherapy in Prostate Cancer | SpringerLinklink.springer.com › book
link.springer.com
Giorgio Arcangeli, Stefano Arcangeli, Lidia Strigari. Pages PDF · Focal Therapy and the Index Lesion Hypothesis in Prostate Cancer. Mitchell Kamrava ...
Journal of Experimental & Clinical Cancer Research - BioMedSearch
www.biomedsearch.com
Stefano Arcangeli - ; Sara Gomellini - ; Giorgio Arcangeli - ;. Marcello Benassi ...
All web results to the name "Stefano Arcangeli"
Radiotherapy: Arcangeli, S - Expertscape.com
expertscape.com
1: Editorial: Moderate hypofractionation for prostate cancer Arcangeli, Stefano / Arcangeli, Giorgio.· Stefano Arcangeli: Department of Radiation Oncology, San Camillo-Forlanini Hospitals, Rome, Italy. · Oncotarget · Pubmed # ABSTRACT: -- No abstract -- 2: Review: Consensus statements on ablative radiotherapy for oligometastatic prostate cancer: A position paper of Italian ...
Toxicity and cosmesis outcomes after single fraction partial breast ...cyberleninka.org › article
cyberleninka.org
Paola Pinnaro , Stefano Arcangeli , Carolina Giordano , Giorgio Arcangeli , Fabrizio Ambesi Impiombato , Valentina Pinzi1, Giuseppe laccarino2, ...
Moderate hypofractionation for prostate cancer | Oncotarget
www.oncotarget.com
https://doi.org oncotarget Stefano Arcangeli, Giorgio Arcangeli
Toxicity and cosmesis outcomes after single fraction partial breast...
go.gale.com
Authors: Paola Pinnarò [1]; Stefano Arcangeli [1]; Carolina Giordano [1]; Giorgio Arcangeli [1]; Fabrizio Ambesi Impiombato [1]; Valentina Pinzi [1]; Giuseppe ...
Ge.Ar. S.a.s. di Arcangeli Giorgio
www.edilizia.com
L'azienda Ge.Ar. S.a.s. consolidamenti di Arcangeli Giorgio è specializzata in consolidamento di edifici e terreni, micropali, pali, tiranti, chiodature,...
Phase II study of a four-week hypofractionated external beam...
moh-it.pure.elsevier.com
Guy Soete ; Stefano Arcangeli ; Gert De Meerleer ; Valeria Landoni ; Valerie Fonteyne ; Giorgio Arcangeli ; Wilfried De Neve ; Guy Storme. Istituto Regina Elena.
Hypofractionated fractionation
secure.elsevierhealth.com
Giorgio Arcangeli, Jack Fowler, Sara Gomellini, Stefano Arcangeli, Biancamaria Saracino, Maria Grazia Petrongari, Marcello Benassi, Lidia Strigari et al.
sorted by relevance / date